Jun 30 |
Is Madrigal Pharmaceuticals a Millionaire Maker?
|
Jun 16 |
Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word.
|
Jun 15 |
Where Will Madrigal Pharmaceuticals Be in 3 Years?
|
Jun 12 |
Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade
|
Jun 12 |
Madrigal Pharmaceuticals: The GLP-1 Threat May Be Overcooked
|
Jun 11 |
Wolfe starts Madrigal at outperform, cites Rezdiffra launch
|
Jun 10 |
Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals
|
Jun 9 |
Madrigal May Not Be Able To Shrug GLP-1 Drugs For Long
|
Jun 6 |
Madrigal Pharmaceuticals Announces New Data from the Phase 3 MAESTRO-NASH Study of Rezdiffra™ (resmetirom) Presented at the EASL Congress
|
Jun 5 |
What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?
|